BAMUNGEN LABORATORIES CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. oral vaccine antigens for human chronic diseases
2. oral vaccine antigens for animals
3. recombinant proteins
2. oral vaccine antigens for animals
3. recombinant proteins
The content above was translated by Ai
Founded Year
2018
Unified Business No.
28114383
Status
Active
Number of Employees
0
Total Paid-in
Capital
11,200,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Bamungen Laboratories Co., Ltd was founded on June 08, 2018 and is located in the Biomedical Park of Zhubei City, Hsinchu County, Taiwan, ROC.
Bamungen is a company that specializes in development and sale recombinant proteins (mostly are vaccine antigens).
We use bacterial (E. coli) expression system to produce affordable recombinant proteins and sell them to diagnostics and vaccine companies to develop their products.
The mission of Bamungen Labs is to research and develop therapeutic vaccines and diagnostic kits for human chronic diseases to improve human life with biotechnology.
At present, the main business items of Bamungen Labs are development and sell recombinant proteins. In addition to develop vaccine antigens for human chronic disease, Bamungen develop vaccine antigens for animals as well, These recombinant vaccine antigens have a special structure and can be used orally to induce systemic immune responses to prevent pathogenic infections. And these vaccine antigens can be used to produce specific antibodies for diagnostic uses.
Bamungen is a company that specializes in development and sale recombinant proteins (mostly are vaccine antigens).
We use bacterial (E. coli) expression system to produce affordable recombinant proteins and sell them to diagnostics and vaccine companies to develop their products.
The mission of Bamungen Labs is to research and develop therapeutic vaccines and diagnostic kits for human chronic diseases to improve human life with biotechnology.
At present, the main business items of Bamungen Labs are development and sell recombinant proteins. In addition to develop vaccine antigens for human chronic disease, Bamungen develop vaccine antigens for animals as well, These recombinant vaccine antigens have a special structure and can be used orally to induce systemic immune responses to prevent pathogenic infections. And these vaccine antigens can be used to produce specific antibodies for diagnostic uses.
The content above was translated by Ai
